Unnamed: 0,title,date,stock,sentiment
1034771.0,Stocks That Hit 52-Week Lows On Wednesday,2020-05-27 10:44:00-04:00,PRPH,negative
1034772.0,"ProPhase Labs Q1 EPS $(0.070) Up From $(0.090) YoY, Sales $1.900M Down From $2.318M YoY",2020-05-12 08:03:00-04:00,PRPH,neutral
1034773.0,Stocks That Hit 52-Week Lows On Wednesday,2020-05-06 10:37:00-04:00,PRPH,negative
1034774.0,Stocks That Hit 52-Week Lows On Monday,2020-05-04 10:55:00-04:00,PRPH,negative
1034775.0,ProPhase Labs FY19 EPS From Continuing Operations $(0.27) vs $(0.14) In FY18,2020-03-25 08:54:00-04:00,PRPH,neutral
1034776.0,ProPhase Labs Reports $0.25/Share Special Dividend,2019-11-20 16:15:00-05:00,PRPH,positive
1034777.0,"ProPhase Labs Q3 EPS $(0.04) Up From $(0.09) YoY, Sales $2.8M Up From $2.44M YoY",2019-11-12 09:39:00-05:00,PRPH,neutral
1034778.0,Stocks That Hit 52-Week Lows On Tuesday,2019-10-29 10:53:00-04:00,PRPH,negative
1034779.0,Stocks That Hit 52-Week Lows On Tuesday,2019-08-20 10:55:00-04:00,PRPH,negative
1034780.0,"ProPhase Labs Q2 EPS $(0.11) Down From $(0.02) YoY, Sales $1.65M Down From $3.186M YoY",2019-08-12 08:03:00-04:00,PRPH,neutral
1034781.0,"ProPhase Labs Q1 EPS $(0.09) Down From $0.00 YoY, Sales $2.32M Down From $3.407M YoY",2019-05-14 08:19:00-04:00,PRPH,neutral
1034782.0,"ProPhase Labs FY18 EPS $(0.14) vs $(0.14) In FY17, Sales $13.1M vs $9.9M In FY17",2019-03-26 08:05:00-04:00,PRPH,neutral
1034783.0,"Prophase Labs, Inc. Appoints Monica Brady As Chief Financial Officer",2019-01-17 17:11:00-05:00,PRPH,neutral
1034784.0,"Stocks Trading Ex Dividend For Wed., Jan. 9, 2019",2019-01-09 10:53:00-05:00,PRPH,neutral
1034785.0,"Stocks That Will Be Trading Ex Dividend Wed., Jan. 9, 2019",2019-01-08 10:20:00-05:00,PRPH,neutral
1034786.0,ProPhase Labs Reports Special Cash Dividend Of $0.25/Share,2018-12-26 09:15:00-05:00,PRPH,positive
1034787.0,"ProPhase Labs Q3 EPS $(0.09) Down From $(0.05) YoY, Sales $2.44M Down From $3.04M YoY",2018-11-14 07:30:00-05:00,PRPH,neutral
1034788.0,"The Daily Biotech Pulse: Merck's Keytruda Secures Approval For Expanded Label, ProPhase Labs Q2 Loss Narrows",2018-08-21 08:40:00-04:00,PRPH,positive
1034789.0,"ProPhase Labs, Inc. Late Monday Reported Q2 EPS $(0.02) Up From $(0.14) YoY, Sales $3.19M Up From $1.905M YoY",2018-08-21 08:30:00-04:00,PRPH,neutral
1034790.0,"ProPhase Labs to Restate Certain Financials Due To Income Tax Benefit Error; EPS For FY17 Drops, Other Quarterly Results Still Uncertain",2018-08-15 06:03:00-04:00,PRPH,positive
1034791.0,45 Biggest Movers From Yesterday,2018-06-06 04:35:00-04:00,PRPH,neutral
1034792.0,42 Biggest Movers From Friday,2018-05-29 05:03:00-04:00,PRPH,neutral
1034793.0,36 Biggest Movers From Friday,2018-05-21 04:54:00-04:00,PRPH,neutral
1034794.0,24 Stocks Moving In Friday's Pre-Market Session,2018-05-18 08:04:00-04:00,PRPH,neutral
1034795.0,"Benzinga's Daily Biotech Pulse: Verastem Uprooted On Stock Offering, Titan Pharma Earnings",2018-05-16 08:10:00-04:00,PRPH,neutral
1034796.0,37 Stocks Moving In Tuesday's Mid-Day Session,2018-05-15 12:32:00-04:00,PRPH,neutral
1034797.0,ProPhase Labs Shares Up 9.0% After Co. Reported Q1 Sales Up YoY,2018-05-15 10:22:00-04:00,PRPH,positive
1034798.0,"Benzinga's Daily Biotech Pulse: Aytu Rallies On Earnings, Evolus Awaits FDA Verdict, BofA Conference Underway",2018-05-15 08:44:00-04:00,PRPH,positive
1034799.0,ProPhase Labs Late Monday Reported Q1 EPS Breakeven vs $0.95 In Same Qtr. Last Year Sales $3.41M Up From $771K YoY,2018-05-15 08:40:00-04:00,PRPH,neutral
1034800.0,48 Biggest Movers From Yesterday,2018-05-15 04:26:00-04:00,PRPH,neutral
1034801.0,36 Stocks Moving In Monday's Mid-Day Session,2018-05-14 12:50:00-04:00,PRPH,neutral
1034802.0,54 Biggest Movers From Yesterday,2018-05-10 05:16:00-04:00,PRPH,neutral
1034803.0,48 Stocks Moving In Wednesday's Mid-Day Session,2018-05-09 12:56:00-04:00,PRPH,neutral
1034804.0,53 Biggest Movers From Yesterday,2018-05-09 05:37:00-04:00,PRPH,neutral
1034805.0,Mid-Afternoon Market Update: Dow Down 125 Points; Impinj Shares Spike Higher,2018-05-08 14:54:00-04:00,PRPH,positive
1034806.0,36 Stocks Moving In Tuesday's Mid-Day Session,2018-05-08 14:26:00-04:00,PRPH,neutral
1034807.0,ProPhase Labs Shares Up 44.5% After Co. Earlier Announced Special $1.00/Share Cash Dividend; Stock May Also Be Played As Low-Float Issue,2018-05-08 13:22:00-04:00,PRPH,positive
1034808.0,"ProPhase Labs Shares Resume Trade, Pull Back From Session High, Now Up 63%",2018-05-08 10:51:00-04:00,PRPH,positive
1034809.0,"ProPhase Shares Up Sharply Following News Of $1/Share Special Dividend; BZ NOTE: Stock Likely Also Being Played As Low-Float Issue, Has ~11M Shares Outstanding",2018-05-08 10:47:00-04:00,PRPH,positive
1034810.0,"ProPhase Labs Shares Halted On Circuit Breaker, Up 76.4%",2018-05-08 10:46:00-04:00,PRPH,positive
1034811.0,ProPhase Labs Announces Special $1.00/Shares Cash Dividend,2018-05-08 03:36:00-04:00,PRPH,positive
1034812.0,"ProPhase Labs Reports FY17 EPS $2.67 vs $(0.17) In FY16, Sales $9.867M vs $4.206M YoY",2018-03-21 09:08:00-04:00,PRPH,neutral
1034813.0,Watch Shares of ProPhase Labs After the Company Earlier Announced Termination of its Shareholder Rights Agreement,2018-02-21 07:29:00-05:00,PRPH,positive
1034814.0,"ProPhase Labs, Inc. Announces Final Results of Its Tender Offer",2017-12-21 16:00:00-05:00,PRPH,neutral
1034815.0,ProPhase Labs Reports Prelim. Results For Tender Offer Of 1.7M Shares At $2.30/Share,2017-12-19 16:30:00-05:00,PRPH,positive
1034816.0,ProPhase Labs Late Mon. Reported Commencement Of Tender Offer To Buyback Up To 1.7M Shares At $2.30/Share,2017-11-21 10:49:00-05:00,PRPH,positive
1034817.0,"ProPhase Labs Reports Quarter Ended EPS $(0.05) vs $(0.05) In Prior Year Period, Sales $3M vs $1.4M In Prior Year Period",2017-11-13 08:31:00-05:00,PRPH,neutral
1034818.0,"Prophase Labs, Inc. Reports Intention to Commence Tender Offer to Repurchase Up to 1.7M Shares of Its Common Stock At $2.30/Share",2017-11-10 08:02:00-05:00,PRPH,positive
1034819.0,"ProPhase Labs Announces Prelim Results Of Tender Offer; 4,323,335 Shares Tendered At $9.9M",2017-09-26 16:06:00-04:00,PRPH,positive
1034820.0,ProPhase Labs Announces Tender Offer To Repurchase 4M Shares At $2.30/Share,2017-08-25 16:16:00-04:00,PRPH,positive
1034821.0,ProPhase Labs to Commence Tender Offer to Repurchase Up to 4M Shares of Its Common Stock,2017-08-16 04:21:00-04:00,PRPH,positive
1034822.0,"ProPhase Labs Reports Q2 EPS $(0.09) vs $(0.08) In Same Qtr. Last Year, Sales $1.9M",2017-08-11 08:03:00-04:00,PRPH,neutral
1034823.0,"ProPhase Labs Announces 1,061,980 Shares Common Stock",2017-06-13 16:31:00-04:00,PRPH,positive
1034824.0,"ProPhase Labs Reports Q1 EPS $0.99 vs $(0.08) In Same Qtr. Last Year, Sales $771K vs $1.016M YoY",2017-05-15 08:31:00-04:00,PRPH,neutral
1034825.0,"UPDATE: ProPhase Says Sees Cash Resources Further Reduced as a Consequence of 6 Items, Including Required Payments of Retained Liabilities, One-Time Costs for Restructuring, Etc.",2017-04-05 16:11:00-04:00,PRPH,negative
1034826.0,UPDATE: ProPhase Says Received Net Proceeds from Sale of Cold-EEZE of ~$39.3M After Deductions,2017-04-05 16:10:00-04:00,PRPH,neutral
1034827.0,ProPhase Labs Issues Shareholder Update,2017-04-05 16:10:00-04:00,PRPH,neutral
1034828.0,"ProPhase Labs Reports Q4 EPS $(0.17) vs. YoY $(0.21), Sales $21M vs. YoY $20.6M",2017-02-27 08:01:00-05:00,PRPH,neutral
1034829.0,Mylan Acquires Cold-EEZE Brand From ProPhase to Further Expand OTC Business For $50M,2017-01-09 07:34:00-05:00,PRPH,positive
1034830.0,"ProPhase Labs, Inc. Announces Agreement to Sell Cold-EEZE Vrand For $50M",2017-01-09 07:31:00-05:00,PRPH,positive
1034831.0,ProPhase Labs Reports Arbitration Decision In Phusion Laboratories/Phosphagenics Dispute,2016-11-16 16:31:00-05:00,PRPH,negative
1034832.0,"ProPhase Labs Reports Quarter Ended EPS $0.01 vs. Prior Year Quarter $0.04, Rev. $5.2M vs. Prior Year Quarter $4.4M",2016-11-14 08:01:00-05:00,PRPH,neutral
1034833.0,"Worst Performing Industries For October 6, 2016",2016-10-06 11:22:00-04:00,PRPH,negative
1034834.0,"Worst Performing Industries For July 26, 2016",2016-07-26 11:21:00-04:00,PRPH,negative
1034835.0,"Top Performing Industries For June 9, 2016",2016-06-09 11:15:00-04:00,PRPH,positive
1034836.0,"ProPhase Labs Reports Q1 EPS $(0.08) vs $(0.09) in Same Qtr. Last Year, Sales $5.37M vs $5.86M YoY",2016-05-10 17:03:00-04:00,PRPH,neutral
1034837.0,"Top Performing Industries For October 19, 2015",2015-10-19 10:45:00-04:00,PRPH,positive
1034838.0,ProPhase Labs 13D Shows Holder Mark Leventhal Holds New 6.2% Stake As of August 17,2015-08-27 12:10:00-04:00,PRPH,neutral
1034839.0,13D Filing from Co. Director Mark Leventhal on ProPhase Labs Shows New 6.2% Stake,2015-08-27 12:09:00-04:00,PRPH,neutral
1034840.0,"Prophase Labs Director Leventhal Buys 145,309 Shares @$1.61/Share -Form 4",2015-08-19 08:05:00-04:00,PRPH,positive
1034841.0,"ProPhase Labs Reports Q2 Loss $0.10, Sales #2.19M, no estimates",2015-08-12 08:03:00-04:00,PRPH,negative
1034842.0,"Prophase Labs Reports Q1 Loss of $0.09/Share vs Loss of $0.05/Share in Same Qtr. Last Year, Sales $5.86M",2015-05-13 16:12:00-04:00,PRPH,negative
1034843.0,"Top Performing Industries For April 22, 2015",2015-04-22 10:34:00-04:00,PRPH,positive
1034844.0,"Top Performing Industries For April 14, 2015",2015-04-14 10:35:00-04:00,PRPH,positive
1034845.0,"Prophase Reports Q4 EPS -$0.05, Sales $8.97M, No Estimates Available",2015-03-25 17:03:00-04:00,PRPH,negative
1034846.0,"ProPhase Labs 13D Filing Shows BML Investment Partners Has 14.6% Stake, Down From 15.02% On Nov 7 2014",2015-03-09 13:19:00-04:00,PRPH,neutral
1034847.0,"Top Performing Industries For November 18, 2014",2014-11-18 10:46:00-05:00,PRPH,positive
1034848.0,"Prophase Labs Shareholder Leonard Buys 48,596 Shares @$1.40/Share -Form 4",2014-09-24 16:27:00-04:00,PRPH,positive
1034849.0,Shares of ProPhase Labs to Resume Trade at 4:45 p.m. EDT,2014-09-10 16:25:00-04:00,PRPH,positive
1034850.0,ProPhase Expects to Report a $3.6 Million Impairment Charge Relating to Its Phusion Joint Venture ,2014-09-10 16:17:00-04:00,PRPH,neutral
1034851.0,ProPhase Issues Release Announcing Finalization of Resolution of Long-Standing Litigations,2014-09-10 16:11:00-04:00,PRPH,neutral
1034852.0,ProPhase Labs Halted News Pending,2014-09-10 16:10:00-04:00,PRPH,neutral
1034853.0,Stocks Hitting 52-Week Lows,2014-08-26 10:03:00-04:00,PRPH,negative
1034854.0,"Worst Performing Industries For August 18, 2014",2014-08-18 12:33:00-04:00,PRPH,negative
1034855.0,"Worst Performing Industries For August 12, 2014",2014-08-12 11:27:00-04:00,PRPH,negative
1034856.0,"ProPhase Labs, Inc. Reports Q2 EPS of $(0.19), Down 73% YOY; Revenue of $1.80M, Down 7% YOY",2014-08-12 08:17:00-04:00,PRPH,neutral
1034857.0,"Top Performing Industries For July 7, 2014",2014-07-07 10:26:00-04:00,PRPH,positive
1034858.0,ProPhase Announces 3M Share Equity Line,2014-05-29 08:01:00-04:00,PRPH,positive
1034859.0,"ProPhase Labs, Inc. Reports Q1 EPS of $(0.05); Revenue of $6.17M",2014-05-12 08:04:00-04:00,PRPH,neutral
1034860.0,"ProPhase Labs, Inc. Reports Q4 EPS of $0.04, Down 56% YOY",2014-03-27 10:12:00-04:00,PRPH,neutral
1034861.0,Morning Market Movers ,2014-01-27 10:28:00-05:00,PRPH,neutral
1034862.0,"ProPhase Labs, Inc. Reports Q3 EPS of $0.08, Down 11% YOY",2013-11-13 08:06:00-05:00,PRPH,neutral
1034863.0,Morning Market Movers ,2013-09-18 10:05:00-04:00,PRPH,neutral
1034864.0,"ProPhase Labs, Inc. Reports Q2 EPS of $(0.11), Down 222% YOY",2013-08-13 08:09:00-04:00,PRPH,neutral
1034865.0,Morning Market Losers ,2013-06-25 09:49:00-04:00,PRPH,negative
1034866.0,"ProPhase Labs, Inc. Reports Q1 EPS of $0.02, Down 78% YOY",2013-05-06 09:29:00-04:00,PRPH,neutral
1034867.0,"ProPhase Labs, Inc. Reports Q4 EPS of $0.03",2013-03-26 08:04:00-04:00,PRPH,neutral
1034868.0,Stocks Hitting 52-Week Highs,2013-02-26 12:02:00-05:00,PRPH,neutral
1034869.0,Prophase Labs Files Prospectus for 2.5M Shares,2012-11-28 08:08:00-05:00,PRPH,positive
1034870.0,"Benzinga's M&A Chatter for Monday October 29, 2012",2012-10-29 16:23:00-04:00,PRPH,neutral
1034871.0,ProPhase Labs Rejects $1.60 Proposal from Matrixx,2012-10-29 08:02:00-04:00,PRPH,negative
1034872.0,"Benzinga's Microcap Movers for Wednesday October 10, 2012",2012-10-10 22:32:00-04:00,PRPH,neutral
1034873.0,"Benzinga's M&A Chatter for Tuesday October 9, 2012",2012-10-09 18:06:00-04:00,PRPH,neutral
1034874.0,Matrixx Initiatives Increases Offer For ProPhase Labs to $1.60/Share in Cash,2012-10-09 07:11:00-04:00,PRPH,neutral
1034875.0,Matrixx Initiatives Files Presentation with SEC Regarding Offer To Acquire ProPhase Labs ,2012-10-09 07:07:00-04:00,PRPH,neutral
1034876.0,Morning Market Movers,2012-10-04 09:51:00-04:00,PRPH,neutral
1034877.0,ProPhase Labs Rejects Non-Binding $1.40 Proposal,2012-09-17 08:03:00-04:00,PRPH,negative
1034878.0,Prophase Reports Q2 EPS $-0.13,2012-08-13 08:14:00-04:00,PRPH,neutral
1034879.0,Cold-EEZE® Announces Launch of NEW Cold-EEZE® Cold Remedy Daytime/Nighttime QuickMelts® and achieves Nationwide Product Distribution  ,2012-07-02 08:03:00-04:00,PRPH,neutral
1034880.0,Morning Market Losers,2012-06-18 09:52:00-04:00,PRPH,negative
1034881.0,Prophase Reports Q1 EPS $(0.05) vs $0.09 Prior Year; Net Sales $6M vs $9.13M (1 Est),2012-05-10 08:35:00-04:00,PRPH,neutral
1034882.0,ProPhase Labs Receives Nasdaq Notice of Non-Compliance ,2011-07-05 08:07:00-04:00,PRPH,neutral
